Tag: C-Guardians
“Incredible results”: C-GUARDIANS II data point to safety and efficacy of...
New findings from the C-GUARDIANS II study indicate that the CGuard Prime carotid stent system (InspireMD) achieves high procedural success, durable early luminal restoration,...
CGuard Prime carotid stent gains US and European approvals for stroke...
InspireMD has been granted premarket approval (PMA) from the US Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the...
InspireMD receives CE-mark recertification under new EU regulatory framework
InspireMD announced today that it has received CE-mark recertification under the European Union’s (EU) new Medical Device Regulation (MDR) regulatory framework for its CGuard...
InspireMD presents positive 30-day follow-up results from C-GUARDIANS clinical trial
InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for...
InspireMD announces completed enrolment in C-Guardians US IDE trial
InspireMD today announced that it has completed enrolment of its ongoing C-Guardians US Investigational Device Exemption (IDE) clinical trial, designed to support potential US...
